Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 35 (3) , 376-385
- https://doi.org/10.1016/s0168-8278(01)00146-5
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Local Angiotensin II and Transforming Growth Factor-β1 in Renal Fibrosis of RatsHypertension, 2000
- Effect of Losartan, An Angiotensin Ii Receptor Antagonist, on Portal Pressure in CirrhosisHepatology, 1999
- Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cellsJournal of Hepatology, 1998
- Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum‐induced rat liver fibrosisPathology International, 1994
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Transforming growth factor-β1: There is regulation beyond transcriptionHepatology, 1993
- Sirius Red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liverLiver International, 1990
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981